Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Understanding Ketamine's Dissociative Effects (KD Study) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at Stanford University is recruiting to study the dissociative effects of ketamine in epilepsy patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Stanford University | Conditions: Epilepsy | Phase 1 | Status: RECRUITING